Revvity Inc (LTS:0KHE)
$ 112.44 0.3 (0.27%) Market Cap: 13.98 Bil Enterprise Value: 16.28 Bil PE Ratio: 93.84 PB Ratio: 1.78 GF Score: 80/100

PerkinElmer Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 11:30PM GMT
Release Date Price: $101.22 (+1.68%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. We're going to go ahead and get started. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, PerkinElmer. We'll do a breakout right after in the Olympic Room. And with that, let me turn it over to Prahlad.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Thank you, Tycho. Good afternoon. I'm excited to share with you some of the great progress that we have been making at PerkinElmer. 2019 was another year of rapid transformation at the company, one that has set us up on a solid footing for 2020 and beyond.

Before I move forward with the presentation, I wanted to invite your attention to our safe harbor statement and to visit our website for additional disclosures regarding any forward-looking statements that are made during the presentation today.

At PerkinElmer, we are unwaveringly committed to our mission of innovating for a healthier world. It is a basic tenet in our DNA and one

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot